Diagnosing small bowel carcinoid tumor in a patient with oligometastatic prostate cancer imaged with PSMA-Targeted [F-18] DCFPyL PET/CT: Value of the PSMA-RADS-3D Designation

被引：9

作者：

Shenderov, Eugene ^{[1
]}

Gorin, Michael A. ^{[1
,2
,3
,4
]}

Kim, Seohyun ^{[1
]}

Johnson, Pamela T. ^{[4
]}

Allaf, Mohamad E. ^{[2
,3
]}

Partin, Alan W. ^{[2
,3
]}

Pomper, Martin G. ^{[1
,2
,3
,4
,5
]}

Antonarakis, Emmanuel S. ^{[1
]}

Pienta, Kenneth J. ^{[1
,2
,3
,5
]}

Rowe, Steven P. ^{[2
,3
,4
]}

机构：

[1] Johns Hopkins Sch Med, Sidney Kimmel Comprehens Canc Ctr, Dept Med Oncol, Baltimore, MD USA

[2] James Buchanan Brady Urol Inst, Baltimore, MD USA

[3] Dept Urol, Baltimore, MD USA

[4] Russell H Morgan Dept Radiol & Radiol Sci, Baltimore, MD USA

[5] Dept Pharmacol & Mol Sci, Baltimore, MD USA

来源：

UROLOGY CASE REPORTS | 2018年 / 17卷

关键词：

Prostate cancer; PSMA; Carcinoid;

D O I：

10.1016/j.eucr.2017.12.011

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

Radiotracers targeting prostate-specific membrane antigen (PSMA), including [F-18] DCFPyL, have been extensively investigated as a means to image prostate cancer more accurately. We present the case of a man with oligometastatic prostate cancer who was also diagnosed with a metastatic small bowel carcinoid tumor following the detection of indeterminate findings on a [F-18] DCFPyL PET and discuss how this case highlights the utility of a newly proposed reporting system for PSMA-targeted PET (PSMA-RADS version 1.0). (C) 2018 The Authors. Published by Elsevier Inc.

引用

页码：22 / 25

页数：4

共 5 条

[1] Metastatic Poorly Differentiated Prostatic Carcinoma With Neuroendocrine Differentiation Negative on 68Ga-PSMA PET/CT [J].

Chakraborty, Partha Sarathi ;

Tripathi, Madhavi ;

Agarwal, Krishan Kant ;

Kumar, Rajeev ;

Vijay, Maneesh Kumar ;

Bal, Chandrasekhar .

CLINICAL NUCLEAR MEDICINE, 2015, 40 (02) :E163-E166

[2]

Jha A, 2017, J NUCL MED, V58

[3] PET imaging of prostate-specific membrane antigen in prostate cancer: current state of the art and future challenges [J].

Rowe, S. P. ;

Gorin, M. A. ;

Allaf, M. E. ;

Pienta, K. J. ;

Iran, P. T. ;

Pomper, M. G. ;

Ross, A. E. ;

Cho, S. Y. .

PROSTATE CANCER AND PROSTATIC DISEASES, 2016, 19 (03) :223-230

[4] Imaging of metastatic clear cell renal cell carcinoma with PSMA-targeted 18F-DCFPyL PET/CT [J].

Rowe, Steven P. ;

Gorin, Michael A. ;

Hammers, Hans J. ;

Javadi, M. Som ;

Hawasli, Hazem ;

Szabo, Zsolt ;

Cho, Steve Y. ;

Pomper, Martin G. ;

Allaf, Mohamad E. .

ANNALS OF NUCLEAR MEDICINE, 2015, 29 (10) :877-882

[5] Pearls and pitfalls in clinical interpretation of prostate-specific membrane antigen (PSMA)-targeted PET imaging [J].

Sheikhbahaei, Sara ;

Afshar-Oromieh, Ali ;

Eiber, Matthias ;

Solnes, Lilja B. ;

Javadi, Mehrbod S. ;

Ross, Ashley E. ;

Pienta, Kenneth J. ;

Allaf, Mohamad E. ;

Haberkorn, Uwe ;

Pomper, Martin G. ;

Gorin, Michael A. ;

Rowe, Steven P. .

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 (12) :2117-2136

← 1 →